Synergistic Therapeutic Microvesicle Systems
Legal Citation
Summary of the Inventive Concept
Integrating patented therapeutic microvesicles with AI, IoT, blockchain, and nanomaterials to create a more powerful, personalized, and efficient system for treating gastrointestinal disorders
Background and Problem Solved
The original patent disclosed therapeutic microvesicles of probiotic bacteria, but limitations in production, quality control, and patient treatment outcomes necessitate the development of more advanced systems. This inventive concept addresses these limitations by combining the patented microvesicles with cutting-edge technologies
Detailed Description of the Inventive Concept
The synergistic system comprises a therapeutic microvesicle composition, an AI-powered quality control system, a blockchain-based tracking system, a nanomaterial-based delivery system, and an IoT-enabled device for real-time monitoring. The system enables personalized treatment, enhanced microvesicle production, and secure tracking of patient outcomes. The AI-powered quality control system ensures microvesicle purity and consistency, while the blockchain-based tracking system guarantees the authenticity of the microvesicles. The nanomaterial-based delivery system targets the release of microvesicles in the gut, and the IoT-enabled device monitors treatment efficacy in real-time
Novelty and Inventive Step
The new claims introduce the integration of AI, IoT, blockchain, and nanomaterials with the patented therapeutic microvesicles, providing a non-obvious and innovative solution to the limitations of the original patent
Alternative Embodiments and Variations
Alternative embodiments may include using different AI algorithms, blockchain platforms, or nanomaterials. Variations could involve integrating the synergistic system with other healthcare technologies, such as telemedicine or electronic health records
Potential Commercial Applications and Market
The synergistic therapeutic microvesicle system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the treatment of gastrointestinal disorders. The system's ability to provide personalized, efficient, and secure treatment outcomes could revolutionize the industry and create new market opportunities
Original Patent Information
| Patent Number | US 11,857,582 |
|---|---|
| Title | Therapeutic microvesicles of probiotic bacteria |
| Assignee(s) | BioGaia AB |